Researchers from the University of Alberta in Canada have published initial finding relating to a potential new cancer treatment. They have shown that a chemical previously used to treat rare metabolic illnesses also causes regression in several cancers including lung, breast and brain tumours. The chemical is called dichloroacetate (DCA) and is not patented or owned by any pharmaceutical company so it would be inexpensive to use. DCA is not patentable as a molecule. There is no incentive for private companies to spend the millions of dollars needed to get DCA approved as a cancer treatment by the FDA (Food and Drugs Administration). This is where we, all of us, need to step in. We intend for TheDCAsite.com to be the meeting place, for the world, where all the important information on DCA is gathered and shared.

DCA works by activating an important enzyme in mitochondria in cells. Mitochondria produce energy in cells and are known to malfunction in cancerous cells. Dr. Evangelos Michelakis, the cardiologist at the University of Alberta who is leading the research suggests that DCA is actually able to reactivate mitochondrial function in cancer-damaged cells, without affecting surrounding healthy cells.

Dr Michelakis and his colleagues are keen to continue clinical trials of the drug, but with no potential profit, private sponsors are limited. They are appealing to the public for donations to continue research into this potential stride forward in the fight against cancer (see their website [link to www.dca.med.ualberta.ca] ).

Another interesting development is that people with cancer who are desperate to find a way to prolong their lives are actually taking DCA before clinical trials have been conducted. The Canadian Cancer Society has warned people not to do this, but a website ( [link to www.thedcasite.com] has been set up on which advice is given and testimonials are posted of patients who are actually taking the drug.

There is a testimonial one the www.thedcasite.com homepage that states:

"After the news story in the Belgium press of two terminally ill cancer patients who used DCA and are now on the road to recovery, the Belgium people are asking questions. "It has brought a lot commotion in Belgium. All the people are wondering why they haven’t heard from DCA any sooner! And they wonder why it isn’t recognized yet as an official medicine for cancer! They are shocked!"

Gerson therapy is another treatment for cancer that public healthcare ignores.